A high-resolution circulating metabolic atlas of lung adenocarcinoma progression supports early and accurate diagnosis
Authors:
Open Access
- 10 August 2026
- journal article
- Published by Elsevier in Cell Reports Medicine
- Vol. 7 (8) , 102991
Abstract
No abstract availableKeywords
Funding Information
- Sichuan Provincial Science and Technology Support Program (2024YFHZ0176)
- National Key Research and Development Program of China (2025YFE0206800)
- National Natural Science Foundation of China (82422042)
- National Natural Science Foundation of China (82372148)
- National Natural Science Foundation of China (824B2059)
- Shanghai Jiao Tong University (YG2023ZD08)
- Shanghai Jiao Tong University (YG2024ZD07)
This publication has 68 references indexed in Scilit:
- Electronic health records improve the diagnosis and prognosis of pulmonary fungal infections in lung cancer patientsView, 2026
- Lung Cancer in Nonsmoking IndividualsJAMA, 2025
- Unveiling large multimodal models in pulmonary CT: A comparative assessment of generative AI performance in lung cancer diagnosticsView, 2025
- LcProt: Proteomics‐based identification of plasma biomarkers for lung cancer multievent, a multicentre studyClinical and Translational Medicine, 2025
- Opportunistic Screening With Low-Dose Computed Tomography and Lung Cancer Mortality in ChinaJAMA Network Open, 2023
- Advanced mass spectrometric and spectroscopic methods coupled with machine learning for in vitro diagnosisView, 2022
- Integrative Serum Metabolic Fingerprints Based Multi‐Modal Platforms for Lung Adenocarcinoma Early Detection and Pulmonary Nodule ClassificationAdvanced Science, 2022
- Blood protein biomarkers in lung cancerCancer Letters, 2022
- Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation setAnnals of Oncology, 2021
- Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating ProteinsJAMA Oncology, 2018